Patents by Inventor Jorge Jacot

Jorge Jacot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120065203
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds.
    Type: Application
    Filed: November 22, 2011
    Publication date: March 15, 2012
    Applicant: The Institute for Pharmaceutical Discovery, LLC
    Inventors: Janet Sredy, Jorge Jacot
  • Publication number: 20100324105
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds.
    Type: Application
    Filed: August 30, 2010
    Publication date: December 23, 2010
    Inventors: Janet Sredy, Jorge Jacot
  • Publication number: 20060270625
    Abstract: The invention describes a novel combination of neutraceuticals. The invention also provides novel kits comprising a novel combination of neutraceuticals. The invention also provides methods for treating symptoms or delaying the progression of neuropathy, e.g., diabetic neuropathy, ischemic neuropathy, metabolic neuropathy, neuropathy due to aging, HIV neuropathy, chemotherapeutic-induced neuropathy, para-neoplastic neuropathy, metabolic neuropathy, and the like.
    Type: Application
    Filed: May 11, 2006
    Publication date: November 30, 2006
    Applicant: Eastern Virginia Medical School
    Inventors: Aaron Vinik, Jorge Jacot
  • Publication number: 20060074114
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds.
    Type: Application
    Filed: November 15, 2005
    Publication date: April 6, 2006
    Inventors: Janet Sredy, Jorge Jacot
  • Patent number: 6964980
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds.
    Type: Grant
    Filed: March 26, 2003
    Date of Patent: November 15, 2005
    Assignee: The Institute for Pharmaceutical Discovery, Inc.
    Inventors: Janet Sredy, Jorge Jacot
  • Publication number: 20030216452
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds.
    Type: Application
    Filed: March 26, 2003
    Publication date: November 20, 2003
    Applicant: The Institute for Pharmaceutical Discovery, Inc.
    Inventors: Janet Sredy, Jorge Jacot
  • Patent number: 6555568
    Abstract: Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds.
    Type: Grant
    Filed: December 1, 1999
    Date of Patent: April 29, 2003
    Assignee: Institute for Pharmaceutical Discovery, L.L.C.
    Inventors: Janet Sredy, Jorge Jacot